Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wendy's (WEN) upgraded to Buy from Neutral at Longbow with analyst Alton Stump saying his conversations with U.S. Wendy's franchisees leads him to estimate that domestic franchised same-store sales are up 2%-2.5% to date in the first quarter. 2. Barclays (BCS) upgraded to Neutral from Sell at Goldman Sachs with analyst Martin Leitgeb citing the company's capital progress and less risk from financial regulation for the upgrade. 3. Eaton (ETN) upgraded to Neutral from Underperform at BofA/Merrill with analyst Andrew Orbin saying management outlined its long-term strategy for Industrial and Electrical segments growth and said a recent inflection in Electrical provides better visibility on margins. 4. Splunk (SPLK) upgraded to Buy from Hold at Argus with analyst Joseph Bonner saying the company is in a fast-growing market, though its success will depend on the execution of a ramp in software sales along with capturing market share without pressure on margins. 5. Dollar Tree (DLTR) upgraded to Overweight from Equal Weight at Barclays with analyst Karen Short saying she views the company's outlook as conservative and believes the recent share selloff provides an attractive entry point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).

JPMorgan raised the firm's price target on Barclays to 240 GBp from 220 GBp and keeps an Overweight rating on the shares.